Patent · US Active

Methods for overcoming glucocorticoid resistance and for determining glucocorticoid resistance potential in cancer

US10457946B2 · kind B2 · utility

0Cited by
1References
38Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 16, 2014
Grant dateOct 29, 2019
Priority date
Expiry dateSep 16, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides methods for overcoming glucocorticoid resistance of cancers by inhibition of CASP1. Also disclosed are diagnostic methods for determining glucocorticoid resistance potential by measuring expression level or promoter methylation status of CASP1 gene and/or NLRP3 gene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.